Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.

BACKGROUND: Our near-real-time safety monitoring of 16 adverse events (AEs) following COVID-19 mRNA vaccination identified potential elevation in risk for six AEs following primary series and monovalent booster dose administration. The crude association with AEs does not imply causality. Accordingly...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoaibi, Azadeh, Lloyd, Patricia C., Wong, Hui-Lee, Clarke, Tainya C., Chillarige, Yoganand, Do, Rose, Hu, Mao, Jiao, Yixin, Kwist, Andrew, Lindaas, Arnstein, Matuska, Kathryn, McEvoy, Rowan, Ondari, Michelle, Parulekar, Shruti, Shi, Xiangyu, Wang, Jing, Lu, Yun, Obidi, Joyce, Zhou, Cindy K., Kelman, Jeffrey A., Forshee, Richard A., Anderson, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266501/
https://www.ncbi.nlm.nih.gov/pubmed/37344261
http://dx.doi.org/10.1016/j.vaccine.2023.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266501/
https://www.ncbi.nlm.nih.gov/pubmed/37344261
http://dx.doi.org/10.1016/j.vaccine.2023.06.014

Ejemplares similares